Gubantes, Roseminda S.
HRN: 21-88-74 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/11/2022
CEFTRIAXONE 1G (VIAL)
09/11/2022
09/17/2022
IVT
2 G
Once A Day
UTI
Waiting Final Action